A randomized, double-blind, placebo-controlled phase I clinical trial to evaluate the safety and immunogenicity of the Novel Coronavirus inactivated vaccine (Vero cells) in healthy individuals 18 years of age and older : A randomized, double-blind, placebo-controlled phase I clinical trial to evaluate the safety and immunogenicity of the Novel Coronavirus inactivated vaccine (Vero cells) in healthy individuals 18 years of age and older

Medienart:

Klinische Studie

Erscheinungsjahr:

2022

Erschienen:

2022

Enthalten in:

WHO International Clinical Trials Registry Platform - (2022) vom: 19. Apr. Zur Gesamtaufnahme - year:2022

Sprache:

Englisch

Links:

Volltext [kostenfrei]

Themen:

610
Medical Condition: Novel Coronavirus Pneumonia (COVID-19)
Recruitment Status: Not yet recruiting
Study Type: Prevention

Anmerkungen:

WHO International Clinical Trials Registry Platform (https://www.who.int/ictrp/en/), First posted: 2021-08-16, Last updated: 2022-11-24

ICTRP ID:

ChiCTR2100050024

Förderinstitution / Projekttitel:

PPN (Katalog-ID):

WHO00784719X